Trial intelligence / Profile preview

Esketamine for postoperative sleep quality and recovery after oral and maxillofacial surgery

ChiCTR2400092053Phase 4Not yet recruiting

Sponsor
School of Stomatology, Fourth Military Medical University
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in sleep disorder (2 arms), sponsored by School of Stomatology, Fourth Military Medical University. Primary endpoint: Sleep disorder one day after surgery. Planned start Nov 2024; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

sleep disorder

Beyond the preview

Go deeper on ChiCTR2400092053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400092053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call